Table 2.
Incidence of permanent teeth with formation anomalies
| Study group | TA (%) | MO (%) | SR (%) | TA or MO (%) | TA, MO, or SR (%) | TFA scores | |
|---|---|---|---|---|---|---|---|
| CC (n = 26) | Range | 0.0–7.1 | 0.0–28.6 | 0.0–57.1 | 0.0–28.6 | 0.0–64.3 | 0.0–22.0 |
| Average | 0.3 | 5.8 | 19.0 | 6.0 | 25.0 | 8.8 | |
| CC + HDC without TBI (n = 14) | Range | 0.0–39.3 | 0.0–14.3 | 0.0–78.6 | 0.0–50.0 | 0.0–100 | 0.0–49 |
| Average | 8.7 | 4.9 | 49.7 | 13.5 | 63.3 | 23.9 | |
| CC + HDC with TBI (n = 6) | Range | 0.0–28.6 | 0.0–21.4 | 28.6–78.6 | 0.0–50 | 28.6–100 | 8.0–50 |
| Average | 6.0 | 8.9 | 54.8 | 14.9 | 69.6 | 25.3 | |
| Total (n = 46) | Range | 0.0–39.3 | 0.0–28.6 | 0.0–78.6 | 0.0–50.0 | 0.0–100.0 | 0.0–50 |
| Average | 3.6 | 5.9 | 33.0 | 9.5 | 42.5 | 15.5 | |
CC, conventional chemotherapy; HDC, high-dose chemotherapy; MO, microdonts; SR, short-rooted teeth; TA, tooth agenesis; TBI, total body irradiation; TFA, tooth formation anomaly.